Desloratadine News
Desloratadine currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Desloratadine with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Dasselta is indicated for the relief of symptoms associated with: allergic rhinitis; urticaria.
- Evidence level: L5
- Predicted indications (20):
- allergic urticaria (100.0%)
- papillary conjunctivitis (100.0%)
- cold urticaria (99.9%)
- pharyngitis (99.9%)
- nasal cavity disease (99.9%)
- acute laryngopharyngitis (99.8%)
- atopic conjunctivitis (99.8%)
- vernal conjunctivitis (99.8%)
- recalcitrant atopic dermatitis (99.8%)
- nasopharyngitis (99.7%)
- IgE responsiveness, atopic (99.6%)
- rosacea conjunctivitis (99.4%)
- common cold (99.0%)
- headache disorder (98.4%)
- trigeminal autonomic cephalalgia (98.3%)
- punctate epithelial keratoconjunctivitis (97.7%)
- Angelucci syndrome (97.6%)
- chronic follicular conjunctivitis (97.6%)
- parasitic conjunctivitis (97.6%)
- serous conjunctivitis except viral (97.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.